Credit Suisse Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) to a hold rating in a research report report published on Friday, January 5th. Credit Suisse Group currently has $73.00 price target on the medical instruments supplier’s stock.

XRAY has been the topic of several other research reports. Deutsche Bank initiated coverage on shares of DENTSPLY SIRONA in a research report on Friday, December 8th. They set a buy rating and a $81.00 price objective on the stock. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a sell rating to a hold rating in a research report on Friday, October 20th. BidaskClub cut shares of DENTSPLY SIRONA from a strong-buy rating to a buy rating in a research report on Saturday, December 2nd. Cleveland Research cut shares of DENTSPLY SIRONA from a buy rating to a neutral rating in a research report on Thursday, October 5th. Finally, Barrington Research upgraded shares of DENTSPLY SIRONA from a market perform rating to an outperform rating and set a $73.00 price objective on the stock in a research report on Monday, November 6th. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $69.15.

DENTSPLY SIRONA (NASDAQ:XRAY) traded down $0.86 during midday trading on Friday, reaching $61.98. 2,040,000 shares of the company’s stock were exchanged, compared to its average volume of 2,160,000. The company has a market cap of $14,240.00, a PE ratio of -17.81, a price-to-earnings-growth ratio of 2.32 and a beta of 1.31. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. DENTSPLY SIRONA has a 12 month low of $52.53 and a 12 month high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $978.99 million. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.66 earnings per share. sell-side analysts predict that DENTSPLY SIRONA will post 2.65 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date was Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.06%.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of DENTSPLY SIRONA stock in a transaction on Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the transaction, the director now directly owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mark Thierer acquired 77,000 shares of the company’s stock in a transaction on Monday, November 13th. The shares were purchased at an average cost of $66.04 per share, with a total value of $5,085,080.00. The disclosure for this purchase can be found here. Company insiders own 1.99% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. BRYN MAWR TRUST Co boosted its stake in DENTSPLY SIRONA by 0.5% during the second quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock worth $782,000 after buying an additional 65 shares during the period. Nordea Investment Management AB boosted its stake in DENTSPLY SIRONA by 0.7% during the second quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock worth $664,000 after buying an additional 75 shares during the period. Security National Bank of Sioux City Iowa IA boosted its stake in DENTSPLY SIRONA by 0.4% during the second quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock worth $1,497,000 after buying an additional 102 shares during the period. Security National Bank of SO Dak lifted its position in shares of DENTSPLY SIRONA by 1.1% during the second quarter. Security National Bank of SO Dak now owns 18,805 shares of the medical instruments supplier’s stock worth $1,219,000 after purchasing an additional 207 shares during the last quarter. Finally, Commonwealth Bank of Australia lifted its position in shares of DENTSPLY SIRONA by 19.0% during the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the last quarter. 96.52% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA (XRAY) Rating Lowered to Hold at Credit Suisse Group” was originally reported by Marea Informative and is owned by of Marea Informative. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://www.mareainformativa.com/dentsply-sirona-xray-stock-rating-lowered-by-credit-suisse-group-updated-updated-updated/125503/.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.